Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000780 · ClinicalTrials.gov registry record

A "Pre-Enrollment" Protocol for HIV-Infected Adolescents

A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
250
Enrollment target
20
Study locations

NCT00000780: Completed study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00000780 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 250 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000780, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
250 participants
Enrollment target
20
Study locations

Study Summary

PRIMARY: To identify, characterize, and co-enroll HIV-infected adolescents into existing and future ACTG (or other NIH-sponsored) HIV treatment protocols through the systematic and recurrent assessment of eligibility. To assess the ability of adolescents enrolled in ACTG 220 to adhere to ACTG (or other NIH-sponsored) HIV treatment protocols; and to define factors that influence the adolescent's ability to enter or adhere to study protocols. SECONDARY: To describe the nature, stage, and progression of HIV infection in adolescents. Little is known about HIV-infected adolescents as a group and, as a result, small numbers of them are currently enrolled in ACTG drug studies. Creative approaches are needed to encourage enrollment of HIV-infected adolescents whose socio-demographic profile has made access to NIH-sponsored research unlikely.

Conditions Studied

HIV Infections

Study Locations (20)

California

  • Long Beach Memorial (Pediatric) - Long Beach
  • Children's Hosp of Los Angeles/UCLA Med Ctr - Los Angeles
  • Children's Hosp of Los Angeles - Los Angeles
  • Los Angeles County - USC Med Ctr - Los Angeles
  • UCLA Med Ctr / Pediatric - Los Angeles
  • Children's Hosp of Oakland - Oakland
  • UCSF / Moffitt Hosp - Pediatric - San Francisco

District of Columbia

  • Georgetown Univ Med Ctr - Washington D.C.
  • Children's Hosp of Washington DC - Washington D.C.
  • George Washington Univ / Hershey Med Ctr - Washington D.C.

Florida

  • Univ of Florida Health Science Ctr / Pediatrics - Jacksonville
  • Univ of Miami (Pediatric) - Miami

Illinois

  • Chicago Children's Memorial Hosp - Chicago
  • Univ of Chicago Children's Hosp - Chicago

Louisiana

  • Tulane Univ / Charity Hosp of New Orleans - New Orleans
  • Tulane Med Ctr Hosp - New Orleans

Alabama

  • Univ of Alabama at Birmingham Schl of Med / Pediatrics - Birmingham

Colorado

  • Children's Hosp of Denver - Denver

Georgia

  • Emory Univ Hosp / Pediatrics - Atlanta

Trial Details

FieldValue
Enrollment Target 250 participants
National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

What the finished NCT00000780 record still lists

NCT00000780 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00000780 names 20 study sites across 9 states, led by California, District of Columbia, Florida.

Frequently Asked Questions

What is clinical trial NCT00000780 about?

NCT00000780 is a clinical study titled "A "Pre-Enrollment" Protocol for HIV-Infected Adolescents". PRIMARY: To identify, characterize, and co-enroll HIV-infected adolescents into existing and future ACTG (or other NIH-sponsored) HIV treatment protocols through the systematic and recurrent assessment of eligibility. To assess the ability of adolescents enrolled in ACTG 220 to adhere to ACTG (or ot...

What is the current status of trial NCT00000780?

This trial is currently completed. The enrollment target is 250 participants.

What conditions does trial NCT00000780 study?

This clinical trial studies the following conditions: HIV Infections.

Who is sponsoring clinical trial NCT00000780?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000780 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00000780's enrollment target sits among peer trials

250 139th of 542 higher than 396 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Related registry views

Source: ClinicalTrials.gov NCT00000780, the US trial registry maintained by the National Library of Medicine. NCT00000780 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.